Results 241 to 250 of about 8,099,813 (387)
A REPORT OF SEVEN OPERATIONS FOR BRAIN TUMORS AND CYSTS. [PDF]
HERM. H. HOPPE
openalex +1 more source
Extracellular matrix: unlocking new avenues in cancer treatment. [PDF]
Lee JJ, Ng KY, Bakhtiar A.
europepmc +1 more source
Loss of the frequently mutated chromatin remodeler ARID1A, a subunit of the SWI/SNF cBAF complex, results in less open chromatin, alternative splicing, and the failure to stop cells from progressing through the cell cycle after DNA damage in bladder (cancer) cells. Created in BioRender. Epigenetic regulators, such as the SWI/SNF complex, with important
Rebecca M. Schlösser+11 more
wiley +1 more source
Evidence for the Synthesis of Vitamin B 12 by Spontaneous Tumors
D. W. Woolley
openalex +1 more source
Chronic TGF‐β exposure drives epithelial HCC cells from a senescent state to a TGF‐β resistant mesenchymal phenotype. This transition is characterized by the loss of Smad3‐mediated signaling, escape from senescence, enhanced invasiveness and metastatic potential, and upregulation of key resistance modulators such as MARK1 and GRM8, ultimately promoting
Minenur Kalyoncu+11 more
wiley +1 more source
SACROCOCCYGEAL TERATOID TUMOR CASE REPORT
George T. Pack, Ralph R. Braund
openalex +2 more sources
THE CYTOTOXIC ACTION OF IMMUNE GAMMA GLOBULIN AND COMPLEMENT ON KREBS ASCITES TUMOR CELLS [PDF]
H. Green+3 more
openalex +1 more source
Artemisinin derivatives differently affect cell death of lung cancer subtypes by regulating GPX4 in patient-derived tissue cultures. [PDF]
Mölleken J+5 more
europepmc +1 more source
We identified adaptor protein ShcD as upregulated in triple‐negative breast cancer and found its expression to be correlated with reduced patient survival and increased invasion in cell models. Using a proteomic screen, we identified novel ShcD binding partners involved in EGFR signaling pathways.
Hayley R. Lau+11 more
wiley +1 more source